Every record from Janoshik · page 43
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019196 | IGF-1 LR3 | TFC | TFC-2508-H6012 | 2025-Q3 | 97.46 | 5.27 | 104.0 | Supplier-supplied | 0 | PASS |
| AX-2025-018823 | SS-31 (Elamipretide) | QSC | QSC-2502-M8050 | 2025-Q3 | 99.93 | 4.98 | 89.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021001 | IGF-1 LR3 | WXT | WXT-2508-G4016 | 2025-Q3 | 96.93 | 4.09 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020562 | Vilon | SSA | SSA-2508-B6325 | 2025-Q3 | 99.04 | 5.35 | 104.8 | Supplier-supplied | 0 | FAIL |
| AX-2025-021024 | Enclomiphene citrate | WXT | WXT-2506-V4278 | 2025-Q3 | 99.32 | 4.34 | 94.7 | Supplier-supplied | 2 | FAIL |
| AX-2025-020747 | Sermorelin | SGN | SGN-2502-Y8932 | 2025-Q3 | 99.05 | 5.36 | 98.1 | Supplier-supplied | 0 | PASS |
| AX-2025-018991 | KPV | FGP | FGP-2506-L1816 | 2025-Q3 | 99.69 | 4.32 | 104.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018824 | SS-31 (Elamipretide) | QSC | QSC-2502-M8050 | 2025-Q3 | 99.93 | 4.67 | 101.5 | Supplier-supplied | 0 | PASS |
| AX-2025-021000 | IGF-1 LR3 | WXT | WXT-2508-G4016 | 2025-Q3 | 96.64 | 3.96 | 103.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020292 | 5-Amino-1MQ | MKM | MKM-2503-H2930 | 2025-Q3 | 99.29 | 4.46 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020071 | Retatrutide | ERP | ERP-2507-P8449 | 2025-Q3 | 98.53 | 1.68 | 89.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019980 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.25 | 3.29 | 90.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019912 | Thymosin α1 | SWB | SWB-2503-S5672 | 2025-Q3 | 99.31 | 3.19 | 101.2 | Supplier-supplied | 0 | PASS |
| AX-2025-018995 | LL-37 | FGP | FGP-2507-L2691 | 2025-Q3 | 99.15 | 4.60 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018834 | Melanotan II | QSC | QSC-2503-D8324 | 2025-Q3 | 99.93 | 5.60 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018800 | AOD-9604 | QSC | QSC-2508-B8479 | 2025-Q3 | 99.86 | 4.19 | 97.7 | Supplier-supplied | 0 | PASS |
| AX-2025-020033 | Retatrutide | ERP | ERP-2506-C7220 | 2025-Q3 | 98.55 | 4.97 | 101.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019880 | AOD-9604 | SWB | SWB-2504-F5003 | 2025-Q3 | 98.96 | 2.63 | 96.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019384 | Gonadorelin | TFC | TFC-2503-A8165 | 2025-Q3 | 99.55 | 4.54 | 96.2 | Supplier-supplied | 0 | PASS |
| AX-2025-019343 | Retatrutide | TFC | TFC-2503-X7298 | 2025-Q3 | 98.75 | 5.55 | 107.1 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-019259 | Retatrutide | TFC | TFC-2508-L6063 | 2025-Q3 | 97.50 | 4.36 | 101.5 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-019214 | BPC-157 | TFC | TFC-2508-W5717 | 2025-Q3 | 99.92 | 3.75 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021012 | BPC-157 | WXT | WXT-2506-M3361 | 2025-Q3 | 98.72 | 3.74 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020946 | KPV | CPC | CPC-2502-M3212 | 2025-Q3 | 98.69 | 2.97 | 89.1 | Supplier-supplied | 4 | FAIL |
| AX-2025-020826 | GHRP-6 | SGN | SGN-2504-X1136 | 2025-Q3 | 98.47 | 3.77 | — | Laboratory-retained | 1 | FAIL |
| AX-2025-019666 | Semaglutide | Homopeptide | HOMO-2505-X2210 | 2025-Q3 | 98.64 | 2.88 | 96.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019039 | BPC-157 | JEEP | JEEP-2506-R3035 | 2025-Q3 | 98.49 | 3.04 | 102.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021288 | Tirzepatide | BCH | BCH-2508-A7737 | 2025-Q3 | 98.59 | 4.73 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-021066 | Liraglutide | WXT | WXT-2504-L4924 | 2025-Q3 | 96.78 | 5.60 | 107.0 | Buyer-sourced | 1 | FAIL |
| AX-2025-020950 | KPV | CPC | CPC-2502-M3212 | 2025-Q3 | 98.10 | 3.02 | 89.8 | Supplier-supplied | 3 | FAIL |
| AX-2025-020798 | PT-141 (Bremelanotide) | SGN | SGN-2505-A9617 | 2025-Q3 | 97.87 | 3.32 | 96.8 | Supplier-supplied | 1 | FAIL |
| AX-2025-019807 | Semaglutide | HJ | HJ-2507-P3933 | 2025-Q3 | 99.41 | 3.99 | 101.9 | Supplier-supplied | 0 | PASS |
| AX-2025-019695 | Semaglutide | HJ | HJ-2507-E3085 | 2025-Q3 | 99.57 | 5.28 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019559 | Semaglutide | Homopeptide | HOMO-2506-M1846 | 2025-Q3 | 98.94 | 5.98 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021266 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 98.50 | 5.20 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020990 | Enclomiphene citrate | CPC | CPC-2505-Y3713 | 2025-Q3 | 98.28 | 6.47 | 104.1 | Buyer-sourced | 2 | FAIL |
| AX-2025-020705 | GHK-Cu | GL Biochem | GLBI-2502-L8987 | 2025-Q3 | 97.27 | 3.72 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019829 | Semaglutide | SWB | SWB-2504-Y4284 | 2025-Q3 | 98.91 | 2.19 | 92.0 | Supplier-supplied | 0 | PASS |
| AX-2025-018794 | AOD-9604 | QSC | QSC-2508-B8479 | 2025-Q3 | 99.60 | 3.26 | 103.2 | Supplier-supplied | 0 | PASS |
| AX-2025-018693 | Retatrutide | QSC | QSC-2502-D6580 | 2025-Q3 | 98.89 | 7.09 | 90.9 | Supplier-supplied | 1 | MARGINAL |